3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
9
Neoplasms
7
Anxiety Disorders
6
Depression
3
Ovarian Neoplasms
2
Chronic Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Tendinopathy
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sarcoma
1
Radiculopathy
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pathophobia
1
Pain, Postoperative
1
Pain
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Nausea
1
Myocarditis
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Lung Diseases, Interstitial
1
Leukemia, Myeloid, Acute
1
Hot Flashes
1
Interventions
pembrolizumab
2
perflutren
1
Vinorelbine
1
Thoracoscopy
1
Surveys and Questionnaires
1
Sulfur Hexafluoride
1
Radiotherapy
1
Prednisone
1
Pemetrexed
1
Paclitaxel
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Hypnosis
1
Health Records, Personal
1
Gemcitabine
1
Drug Therapy
1
Dexamethasone
1
Conscious Sedation
1
Clinical Protocols
1
Carboplatin
1
Bronchoscopy
1
Bronchoalveolar Lavage
1
Blood Pressure
1
Bevacizumab
1
Behavior Therapy
1
Adrenal Cortex Hormones
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lung Diseases, Interstitial
×
Hypnosis
×
Clear all
NCT07173348
2026-06-04
HYPNEA
University Hospital, Geneva
Phase NA
Recruiting
82 enrolled